Secondary progressive multiple sclerosis and Haemoglobin decreased

Summary:

Haemoglobin decreased is found among people with Secondary progressive multiple sclerosis, especially for people who are female, 60+ old.

The study analyzes which people have Haemoglobin decreased with Secondary progressive multiple sclerosis. It is created by eHealthMe based on reports of 22 people who have Secondary progressive multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Secondary progressive multiple sclerosis?

Secondary progressive multiple sclerosis (a stage of ms which comes after relapsing remitting ms in many cases) is found to be associated with 137 drugs and 134 conditions by eHealthMe. Check the latest studies of Secondary progressive multiple sclerosis.

What is Haemoglobin decreased?

Haemoglobin decreased is found to be associated with 2,396 drugs and 3,138 conditions by eHealthMe. Check the latest studies of Haemoglobin decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

22 people who have Secondary Progressive Multiple Sclerosis and Haemoglobin Decreased are studied.

Would you have Haemoglobin decreased when you have Secondary progressive multiple sclerosis?

Gender of people who have Secondary Progressive Multiple Sclerosis and experienced Haemoglobin Decreased *:

female: 72.73 %
male: 27.27 %

Age of people who have Secondary Progressive Multiple Sclerosis and experienced Haemoglobin Decreased *:

Common co-existing conditions for these people *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 36.36%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 18.18%
High Blood Pressure: 4 people, 18.18%
Clinically Isolated Syndrome (individual's first neurological episode, caused by inflammation or demyelination of nerve tissue): 4 people, 18.18%
Pain: 3 people, 13.64%
Joint Swelling: 2 people, 9.09%
Iron Deficiency: 2 people, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
Dyspnea (difficult or laboured breathing): 2 people, 9.09%
Depression: 2 people, 9.09%

Common drugs taken by these people *:

Common symptoms for these people *:

Urinary Tract Infection: 11 people, 50.00%
Haematocrit Decreased: 6 people, 27.27%
Sinusitis (inflammation of sinus): 5 people, 22.73%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 22.73%
Itching: 5 people, 22.73%
Fatigue (feeling of tiredness): 5 people, 22.73%
Lymphocyte Count Decreased: 4 people, 18.18%
Red Blood Cell Count Decreased: 4 people, 18.18%
Memory Loss: 4 people, 18.18%
Blood Creatinine Increased: 4 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haemoglobin decreased?

- Check whether Haemoglobin decreased is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haemoglobin decreased and Secondary progressive multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.